Aurélien Voissière

4PUBLICATIONS
20CO-AUTHORS
Innate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 14, 2025
Dendritic cells: the central partner for cancer immunity.

Léo Laoubi, Elisa Gobbini, Pierre Duplouye

|Mar 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.

Candice Sakref, Alexis Saby, Céline Rodriguez

|Jan 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud

Pageof 1